Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

A Suicide Vector Design for Cells Expressing HIV-1 Regulatory Genes. Edition No. 1

VDM Publishing House, May 2009, Pages: 136


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

In this study, expression profiles of the toxic gene
HSV-1 TK on parental HeLa cells and HeLa cells
expressing HIV-1 regulatory genes was desired to be
assessed. The toxic gene (suicide gene) presumed to
create the desired effect was placed under the
transcriptional control of HIV promoter LTR and so
that the expression of the toxic gene was made
dependent upon the tat regulator gene of HIV. In
order to prevent leaky gene expression stemming from
the basal gene expression from LTR even if it was not
induced by Tat, and thereby having potential to
damage healthy cells, the prerequisite cis-acting DNA
sequences were cloned downstream of the toxic gene.
So that, the transcripts produced could retain in the
nucleus and would require the function of a second
regulator protein ‘Rev’ for being transmitted into
the cytoplasm. However, since the generation of
stable cell lines expressing Tat and Rev proteins
could not be achieved, the possibility of working
with the suicide vector constructed for this purpose
was out of question. In this book, the strategies and
the handicaps will be discussed for researchers who
aim to develop cloning based approaches to prevent
HIV infection.




For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds